Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-06-016839

Director bought 20,000 shares at an average $3.93 ($78,508)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
CITRON JOEL TOMAS Director 2006-03-06 Purchase +300 $3.89 $1,167 291,277 D: show line 1 in the form
CITRON JOEL TOMAS Director 2006-03-06 Purchase +500 $3.90 $1,950 291,777 D: show line 2 in the form
CITRON JOEL TOMAS Director 2006-03-06 Purchase +700 $3.95 $2,765 292,477 D: show line 3 in the form
CITRON JOEL TOMAS Director 2006-03-06 Purchase +100 $3.96 $396 292,577 D: show line 4 in the form
CITRON JOEL TOMAS Director 2006-03-07 Purchase +400 $3.86 $1,544 292,977 D: show line 5 in the form
CITRON JOEL TOMAS Director 2006-03-07 Purchase +100 $3.87 $387 293,077 D: show line 6 in the form
CITRON JOEL TOMAS Director 2006-03-07 Purchase +200 $3.88 $776 293,277 D: show line 7 in the form
CITRON JOEL TOMAS Director 2006-03-07 Purchase +2,700 $3.89 $10,503 295,977 D: show line 8 in the form
Open-market purchases · 20,000 sh · avg $3.93 · $78,508
Loading xslF345X02/rrd110628.xml…